HOTTEST PENNY STOCK PICKS

[ALERTS100%to10000%GAIN]

CURX~~INSIDERS HOLDERS,,FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Jing Dian Ying
(Last) (First) (Middle)
C/O CURANEX PHARMACEUTICALS INC
2 JERICHO PLAZA SUITE 101 B
(Street)
JERICHO NY 11753
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
8/25/25 3. Issuer Name and Ticker or Trading Symbol
Curanex Pharmaceuticals Inc [ CURX ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
X Officer (give title below) Other (specify below)
Secretary
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 3,248,400 D
Common Stock 912,600 I see footnote (1)
Common Stock 7,076,160 I see footnote (2)
Series A Preferred Stock 200,000 D
Series A Preferred Stock 490,000 I